Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS - sprookjes - yvandenbroek - TriplyDB

Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS

Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS

http://www.wikidata.org/entity/Q37454324

about

Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?The three-year incidence of major hemorrhage among older adults initiating chronic dialysis.Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis.Gastrointestinal bleeding in patients on long-term dialysis Management of Atrial Fibrillation in Patients With Kidney Disease.Clopidogrel use in end-stage kidney disease.Anticoagulation in Chronic Hemodialysis: Progress Toward an Optimal Approach.Percutaneous coronary interventions and antiplatelet therapy in renal transplant recipients.Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation.Safety Outcomes of Apixaban Compared With Warfarin in Patients With End-Stage Renal Disease.The role of cGMP and its signaling pathways in kidney disease.Atrial fibrillation and chronic kidney disease: struggling through thick and thin.Antiplatelet agents in hemodialysis.Cardiovascular and Stroke Risk in Japanese Hemodialysis Patients With Atrial Fibrillation.Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study.Mitral valve replacement in a dialysis-dependent patient.Antiplatelet and oral anticoagulant therapies in chronic hemodialysis patients: prescribing practices and bleeding risk.Low-dose aspirin for prevention of cardiovascular disease in patients on hemodialysis: A 5-y prospective cohort study.Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational study.Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation.Warfarin Use in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes.Evaluation of warfarin dose requirements in patients with chronic kidney disease and end-stage renal disease.

P2860

Q26827576-B91619CA-7932-4185-9C05-0721BFFB1810 Q35147637-3C4EA740-F211-4A8B-88C0-B9AE70815405 Q36069462-79E993C3-01C2-4826-9DC7-313F3D37CF6F Q37178928-95102F78-3B4C-4D45-B19B-EE3FB7753271 Q37469045-B2CCEDE9-C658-4D8C-800A-0057696372B0 Q38283422-B53615DC-2CDF-4FEF-9902-0F43307437EB Q38442992-B7F18B8B-A098-497B-928F-C10DC572A2AF Q38672873-2BC225DF-5843-4124-B0D2-98E81E648383 Q38683015-B6DEB7EB-CDB7-4D0E-BDAA-3A9498391C59 Q38800081-5DC1A3B8-63E4-4392-B012-1E7DD38E826F Q38896087-03051261-4275-4AEF-B2E4-1A75B73F94B8 Q38981275-025653D7-1F2B-41FD-B93C-9F63DD19CB9C Q39032565-A88A378E-176E-4821-8F28-6EFCCF63D65D Q39145892-99483D05-5146-495B-A375-3DF709BC508F Q39498134-0C5609BF-7C3A-46FA-B040-C396F7B020F2 Q40480109-E378D347-2031-4F91-BFF2-3997ABAFE9A1 Q40527689-23F08803-5D63-461F-82F0-0234223E0372 Q40773906-FCD4D72F-394E-42D3-BFBA-B79BFD58F55F Q40877690-430640C4-D717-4814-9DCA-A1FEEF2D3313 Q42368986-7DACE962-A7A9-45C5-A950-2118E6DF462D Q45184145-289ADD66-4F75-4B5A-AE53-CB8952C5AA14 Q47106586-9544322F-1943-40B5-B100-5EDA21BF571C Q53089586-70E31014-9111-41EC-9BF8-EF02EE765F4A

P2860

Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS

http://www.wikidata.org/entity/Q37454324

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Major bleeding events and risk ...... alysis: results from the DOPPS

@en

Major bleeding events and risk ...... lysis: results from the DOPPS.

@nl

type

label

Major bleeding events and risk ...... alysis: results from the DOPPS

@en

Major bleeding events and risk ...... lysis: results from the DOPPS.

@nl

prefLabel

Major bleeding events and risk ...... alysis: results from the DOPPS

@en

Major bleeding events and risk ...... lysis: results from the DOPPS.

@nl

P1433

Q37454324-E5073FEE-FB5D-493A-A6EF-4608FC89B568

P1476

Q37454324-1B7B83C9-CF2E-467F-BB06-3FCADE79006D

P2093

Q37454324-0AA109FC-E728-474D-9EE6-8C2837F7CA83

Q37454324-23F9C3EE-7443-4F51-B8DD-C5D90799CFF8

Q37454324-28B9E848-6EAB-4D32-AE6E-F2F7F7916B9E

Q37454324-37123CF6-0337-4B85-8E15-CF557255A7C3

Q37454324-3F75E422-0DE4-4543-9584-2141EFACDEB4

Q37454324-539177E8-5D34-4F41-9D38-CE6B0DCF5CDB

Q37454324-6F34D900-B2F8-4978-87B4-05A41AC3BC1D

Q37454324-7763B937-95B2-4453-8F41-9F437ADA439C

Q37454324-8DAD6820-95C4-4AEF-879D-95748E2AFAD9

Q37454324-C36EDBEE-6FDB-48A4-A27A-BFAB2FB300D7

P2860

Q37454324-037F3C10-468F-4603-81A9-5BEB06141F52

Q37454324-07014DD1-C347-4CB0-A33B-0D132C2742A5

Q37454324-0EF92087-BC80-4C5A-A71C-F213994B3586

Q37454324-14308541-9248-43AF-905B-130C0298CD43

Q37454324-18F929A1-9EF9-4192-A352-79C330896A67

Q37454324-1EB240D4-259F-4426-A312-8F0035651A9D

Q37454324-1F8E558F-C9D3-470B-BC87-E5C620FEA2B2

Q37454324-283F85B2-3E76-4D89-935A-55AE2E4532A4

Q37454324-346CFBC7-96C8-4E94-80F0-F17B15F97D12

Q37454324-38F231B8-5CC9-4D8D-A08E-94C4EA029063

P2888

Q37454324-81A88D33-B211-4872-9098-3FDDCAEDFBFD

P304

Q37454324-2E16DCF4-C994-4C03-AF6E-031286BA4254

P31

Q37454324-1405DA53-A7A2-42F7-A6BD-A314B18E92B2

P356

Q37454324-D6282CBD-88D9-4977-8054-6FB21C50F971

P407

Q37454324-7B51410E-2186-4CC3-B411-D91590DABACC

P433

Q37454324-7313356B-AE3A-43C7-A874-4FF325F8ADE7

P478

Q37454324-5A21C05A-8556-453F-8157-64A1ECC426F6

P577

Q37454324-A83C2199-C089-4E65-9016-8D34143FD6BC

P5875

Q37454324-0E2B8B2B-5AFA-4929-BBA6-D675D0AA99E1

P698

Q37454324-3D6499CE-CE7F-4604-A2C0-718B6EE0BE47

P932

Q37454324-A221D151-B7E3-49F3-B3C2-38BF1595880D

P356

P1433

Kidney International

P1476

Major bleeding events and risk ...... alysis: results from the DOPPS

@en

P2093

Brenda W Gillespie

http://www.w3.org/2001/XMLSchema#string

Bruce M Robinson

http://www.w3.org/2001/XMLSchema#string

Claudio Rigatto

http://www.w3.org/2001/XMLSchema#string

David C Mendelssohn

http://www.w3.org/2001/XMLSchema#string

Francesca Tentori

http://www.w3.org/2001/XMLSchema#string

Jyothi R Thumma

http://www.w3.org/2001/XMLSchema#string

Kevin Chan

http://www.w3.org/2001/XMLSchema#string

Manish M Sood

http://www.w3.org/2001/XMLSchema#string

Maria Larkina

http://www.w3.org/2001/XMLSchema#string

Patricia de Sequera

http://www.w3.org/2001/XMLSchema#string

P2860

Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality

Thromboembolism and anticoagulant management in hemodialysis patients: a practical guide to clinical management

Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment

Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis

Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)

Validation of Clinical Classification Schemes for Predicting Stroke

The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology.

Does warfarin safely prevent clotting of hemodialysis catheters? a review of efficacy and safety.

Considerations in using anticoagulant therapy in special patient populations.

Catheter-related mortality among ESRD patients.

P2888

P304

600-608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2013.170

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236911967

http://www.w3.org/2001/XMLSchema#string

P698

23677245

http://www.w3.org/2001/XMLSchema#string

P932

3885984

http://www.w3.org/2001/XMLSchema#string